semaglutide MASH investigational

Selected indexed studies

• Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities. (Biomedicines, 2026) [PMID:42072449]

_Worker-drafted node — pending editorial review._